BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Redd Bowman KE, Lu P, Vander Mause ER, Lim CS. Advances in delivery vectors for gene therapy in liver cancer. Therapeutic Delivery 2020;11:833-50. [DOI: 10.4155/tde-2019-0076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Montaño-Samaniego M, Bravo-Estupiñan DM, Méndez-Guerrero O, Alarcón-Hernández E, Ibáñez-Hernández M. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters. Front Oncol 2020;10:605380. [PMID: 33381459 DOI: 10.3389/fonc.2020.605380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Huang L, Jiang Y, Liu X, Guo Y, Feng Y, Pan P, Li M, Liu Y. Antheraea pernyi silk fibroin-coated adenovirus as a VEGF165-Ang-1 dual gene delivery vector. Journal of Bioactive and Compatible Polymers. [DOI: 10.1177/08839115221095254] [Reference Citation Analysis]
3 Kamra M, Maiti B, Saha P, Karande AA, Bhattacharya S. Antibody-Conjugated Vitamin E-Derived Liposomes for Targeted Gene Transfer. ACS Appl Bio Mater 2020;3:8375-85. [DOI: 10.1021/acsabm.0c00656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wang Y, Li B, Luo Y, Yang T, Zhao X, Ding P. Virosome, a promising delivery vehicle for siRNA delivery and its novel preparation method. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103490] [Reference Citation Analysis]
5 Fu P, Zhang J, Li H, Mak M, Xu W, Tao Z. Extracellular vesicles as delivery systems at nano-/micro-scale. Adv Drug Deliv Rev 2021;179:113910. [PMID: 34358539 DOI: 10.1016/j.addr.2021.113910] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
6 Yan S, Ren X, Yang J, Wang J, Zhang Q, Xu D. Exosomal miR-548c-5p Regulates Colorectal Cancer Cell Growth and Invasion Through HIF1A/CDC42 Axis. Onco Targets Ther 2020;13:9875-85. [PMID: 33116573 DOI: 10.2147/OTT.S273008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Qu M, Kim H, Zhou X, Wang C, Jiang X, Zhu J, Xue Y, Tebon P, Sarabi SA, Ahadian S, Dokmeci MR, Zhu S, Gu Z, Sun W, Khademhosseini A. Biodegradable microneedle patch for transdermal gene delivery. Nanoscale 2020;12:16724-9. [DOI: 10.1039/d0nr02759f] [Cited by in Crossref: 10] [Article Influence: 5.0] [Reference Citation Analysis]
8 Mohammadinejad R, Dehshahri A, Sagar Madamsetty V, Zahmatkeshan M, Tavakol S, Makvandi P, Khorsandi D, Pardakhty A, Ashrafizadeh M, Ghasemipour Afshar E, Zarrabi A. In vivo gene delivery mediated by non-viral vectors for cancer therapy. J Control Release 2020;325:249-75. [PMID: 32634464 DOI: 10.1016/j.jconrel.2020.06.038] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
9 Xi S, Yang Y, Suo J, Sun T. Research Progress on Gene Editing Based on Nano-Drug Delivery Vectors for Tumor Therapy. Front Bioeng Biotechnol 2022;10:873369. [DOI: 10.3389/fbioe.2022.873369] [Reference Citation Analysis]
10 Lan T, Que H, Luo M, Zhao X, Wei X. Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy. Mol Cancer 2022;21:71. [PMID: 35277177 DOI: 10.1186/s12943-022-01550-8] [Reference Citation Analysis]
11 Iqubal A, Iqubal MK, Khan A, Ali J, Baboota S, Haque SE. Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective. CGT 2020;20:184-94. [DOI: 10.2174/1566523220999200716111502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]